Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009–2012

BACKGROUND: In March 2009, the U.S. Food and Drug Administration licensed an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC [Ixiaro]) for use in adults. The vaccine was licensed based on clinical trial safety data in 3558 JE-VC recipients. It is essential to monitor post...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine
Main Authors: Rabe, Ingrid B., Miller, Elaine R., Fischer, Marc, Hills, Susan L.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5765744/
https://ncbi.nlm.nih.gov/pubmed/25498208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.11.046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items